Opthea Ltd (CKDXF) shareholders
CKDXFOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as CYVNY
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Jun 30, 2025Last filing: 20-F on Sep 15, 2025Score 0/30
$0.01+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Ownership
Who owns Opthea's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Regal Funds Management Pty Limited Joint filing with Regal Partners Limited (32.23%) | 396,818,462 | 32.23% | 13G (passive) amendment | Jul 31, 2024 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
2M shares short
Days to cover
1000.0
At 0M shares a day
Change since last report
-39.2%
From 3M shares
Short volume, 0 days
–
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Opthea's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
See a number that looks wrong?